Amedisys (AMED) Misses Q4 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Amedisys Reports Fourth Quarter and Year End 2017 Financial Results
February 27, 2018 5:00 PM ESTBATON ROUGE, La., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three month period and year ended December 31, 2017.
Three Month Periods Ended December 31, 2017 and 2016
Net service revenue increased $37.9Â million to $404.2Â million compared to $366.3Â million in 2016. Net loss attributable to Amedisys, Inc. of $3.8Â million which is inclusive of a $21.4Â million reduction in net income as a result of the enactment of H.R. 1 (Tax Cuts and Jobs Act), compared to net income attributable to Amedisys, Inc. of $8.9Â million in 2016. Net loss attributable to... More